By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Defence Therapeutics Inc.

Defence Therapeutics Inc. (DTCFF)

OTC Market Data in USD, Fundamentals in CAD
$0.57
+$0.03
+5.56%
Last Update: 29 Aug 2025, 17:19
$31.19M
Market Cap
-9.80
P/E Ratio (TTM)
Forward Dividend Yield
$0.27 - $1.16
52 Week Range

DTCFF Stock Price Chart

Explore Defence Therapeutics Inc. interactive price chart. Choose custom timeframes to analyze DTCFF price movements and trends.

DTCFF Company Profile

Discover essential business fundamentals and corporate details for Defence Therapeutics Inc. (DTCFF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

18 May 2021

Employees

CEO

Sebastien Plouffe

Description

Defence Therapeutics Inc., a biotechnology company, engages in the research and development of biological/biosimilar therapeutic drugs for cancer and infectious diseases. Its proprietary platform is the ACCUMTM technology, which enables precision delivery of vaccine antigens or ADCs in their intact form to target cells. The company focuses on developing dendritic cell cancer vaccines; protein-based vaccine formulation against COVID and infectious diseases; and antibody drug conjugates (ADC) products targeting various cancers. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. Defence Therapeutics Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

DTCFF Financial Timeline

Browse a chronological timeline of Defence Therapeutics Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 31 Mar 2025

EPS came in at -$0.01 .

Earnings released on 31 Dec 2024

EPS came in at -$0.01 .

Earnings released on 30 Sept 2024

EPS came in at -$0.01 .

Earnings released on 30 Jun 2024

EPS came in at -$0.02 .

Earnings released on 31 Mar 2024

EPS came in at -$0.02 .

Earnings released on 31 Dec 2023

EPS came in at -$0.14 .

Earnings released on 30 Sept 2023

EPS came in at -$0.04 .

Earnings released on 29 Jun 2023

EPS came in at -$0.03 .

Earnings released on 31 Mar 2023

EPS came in at -$0.03 .

Earnings released on 31 Dec 2022

EPS came in at -$0.04 .

Earnings released on 30 Sept 2022

EPS came in at -$0.03 .

Earnings released on 21 Jun 2022

EPS came in at -$0.05 .

Earnings released on 31 Mar 2022

EPS came in at -$0.04 .

Earnings released on 31 Dec 2021

EPS came in at -$0.04 .

Earnings released on 26 Nov 2021

EPS came in at -$0.03 .

Earnings released on 30 Jun 2021

EPS came in at -$0.04 .

Earnings released on 31 Mar 2021

EPS came in at -$0.02 .

Earnings released on 31 Dec 2020

EPS came in at -$0.01 .

Earnings released on 30 Sept 2020

EPS came in at -$0.00 .

DTCFF Stock Performance

Access detailed DTCFF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run